Is Werewolf Therapeutics Inc (HOWL) overvalued? · $48.9M cap
Werewolf Therapeutics Inc (HOWL) is a biotechnology company listed on US.
This page asks whether Werewolf Therapeutics Inc (HOWL) looks expensive on cached numbers — not a short thesis.
No cached income statement for HOWL, so there is no earnings base to call rich or cheap.
HOWL currently screens at market cap $48.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HOWL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HOWL stock page for the full model, not this heading.
Not investment advice.